Results from trial show THC/CBD combination significantly reduces agitation for people with dementia at end of life. A combination of CBD and THC rapidly and significantly reduces agitation in hospice-eligible people with dementia, suggest top-line results from the phase 2 LiBBY (Life's End Benefits of cannaBidiol and tetrahYdrocannabinol) clinical trial.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: A combination of CBD and THC rapidly and significantly reduces agitation in hospice-eligible people with dementia, suggest top-line results from the phase 2 LiBBY (Life's End Benefits of cannaBidiol and tetrahYdrocannabinol) clinical trial. The findings were reported for the first time at the Alzheimer's Association International Conference 2026 in London and online.
- Ponto de atenção: results.
- Ponto de atenção: from.
- Ponto de atenção: trial.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.
:quality(85)/d58df475-cc64-4a03-a071-7acbd0d08fcf.jpg)
